Bristol-Myers Squibb
This article was originally published in The Gray Sheet
Executive Summary
Ongoing share repurchase program will be doubled from 25 mil. to 50 mil. shares, the firm reports April 6. A total of 21.2 mil. shares already have been bought back under the program, which was implemented in October 1987. "Current market conditions have created an excellent opportunity to strengthen the company through a purchase of its own shares," BMS Chairman and CEO Richard Gelb states in a same-day release.